HM, C., SJ, M., & PM, M. (2021). Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply. The lancet. Diabetes & endocrinology, 9(4), 201. https://doi.org/10.1016/S2213-8587(21)00055-3
Chicago Style (17th ed.) CitationHM, Colhoun, McGurnaghan SJ, and McKeigue PM. "Microvascular Disease in Diabetes and Severe COVID-19 Outcomes - Authors' Reply." The Lancet. Diabetes & Endocrinology 9, no. 4 (2021): 201. https://doi.org/10.1016/S2213-8587(21)00055-3.
MLA (9th ed.) CitationHM, Colhoun, et al. "Microvascular Disease in Diabetes and Severe COVID-19 Outcomes - Authors' Reply." The Lancet. Diabetes & Endocrinology, vol. 9, no. 4, 2021, p. 201, https://doi.org/10.1016/S2213-8587(21)00055-3.
Warning: These citations may not always be 100% accurate.